Cargando…
Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin association
BACKGROUND: Non-ER nuclear receptor activity can alter estrogen receptor (ER) chromatin association and resultant ER-mediated transcription. Consistent with GR modulation of ER activity, high tumor glucocorticoid receptor (GR) expression correlates with improved relapse-free survival in ER+ breast c...
Autores principales: | Tonsing-Carter, Eva, Hernandez, Kyle M., Kim, Caroline R., Harkless, Ryan V., Oh, Alyce, Bowie, Kathleen R., West-Szymanski, Diana C., Betancourt-Ponce, Mayra A., Green, Bradley D., Lastra, Ricardo R., Fleming, Gini F., Chandarlapaty, Sarat, Conzen, Suzanne D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651939/ https://www.ncbi.nlm.nih.gov/pubmed/31340854 http://dx.doi.org/10.1186/s13058-019-1164-6 |
Ejemplares similares
-
High glucocorticoid receptor expression in the sarcomatous versus carcinomatous elements of Mullerian carcinosarcomas
por: Kurnit, Katherine C., et al.
Publicado: (2022) -
Identification of Differential ER-Alpha Versus ER-Beta Mediated Activation of eNOS in Ovine Uterine Artery Endothelial Cells
por: Pastore, Mayra B., et al.
Publicado: (2016) -
Bioactive Dietary Supplements Reactivate ER Expression in ER-Negative Breast Cancer Cells by Active Chromatin Modifications
por: Meeran, Syed M., et al.
Publicado: (2012) -
KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function
por: Gala, Kinisha, et al.
Publicado: (2018) -
In Vitro Drug Release After Crushing: Evaluation of Xtampza(®) ER and Other ER Opioid Formulations
por: Mayock, Stephen P., et al.
Publicado: (2017)